JamesPaulMaynardMD

Neurology • Cincinnati, OH

Sleep Medicine

Physician

Join to view full profile

Dr. Maynard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Maynard's full profile

Already have an account?

Office
1775 Lexington Ave
Suite 200
Cincinnati, OH 45212
Phone+1 513-533-6325

Education & Training

Medical College of Wisconsin Affiliated HospitalsResidency, Neurology, 1989 - 1992
Medical College of Wisconsin Affiliated HospitalsInternship, Internal Medicine, 1988 - 1989
Medical College of WisconsinClass of 1988
Marquette UniversityB.S., 1980 - 1984

Certifications & Licensure

OH State Medical License 2008 - 2026
KY State Medical License 2006 - 2025
WI State Medical License 1989 - 2025
IN State Medical License 2014 - 2015
IL State Medical License 1995 - 2014
IA State Medical License 1999 - 2002
American Board of Psychiatry and Neurology Neurology
American Board of Psychiatry and Neurology Sleep Medicine

Awards, Honors, & Recognition

Compassionate Care in Neurology Award Medical College of Wisconsin, 1992
US Navy Achievement Medal Secretary of the US Navy, 1980

Publications & Presentations

PubMed

7 citations
Pharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjects.
Ofer Spiegelstein, Jasper Stevens, Joop M. A. van Gerven, Pradeep J. Nathan, James P Maynard
Journal of Psychopharmacology. 2016-05-24

Journal Articles

Efavirenz modulation of sleep spindles and sleep spectral profile
Simen AA, Ma J, Svetnik V, Mayleben D, Maynard J, Roth A, Mixson L, Mogg R, Shera D, George L, Mast TC, Beals C, Stoch A, Struyk A, Shire N, Fraiser L, Journal of sleep research, 1/1/2016
Pharmacokinetics, pharmacodynamics and safety of CEP-26401, a high-affinity histamine-3 receptor antagonist, following single and multiple dosing in healthy subjects
Spiegelstein O, Stevens J, Van Gerven J, Nathan PJ, Maynard JP, Mayleben DW, Hellriegel E, Yang R,, Journal of Psychopharmacology, 1/1/2016

Research History

Lead Physician CTI/CRC2008 - Present